Investing Profile

Martin Alexander Gershon(23)

CEOInvestorFounderVC
Endeavor Life Science Venture Funds is a Series B evergreen fund and Seed and Series A Venture Studio.
gershoncapital.comNew York, New York
Photo of Martin Alexander Gershon, Managing Partner at Endeavor Venture Funds

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Endeavor Venture Funds Managing Partner
$500K - $25.0M
$10.0M
95
CompanyStageDateRound SizeTotal Raised
QuantHealth
Series AAug 2023$2.5M
$18M
Co-investors: Ittai Harel (Pitango Venture Capital), Cris De Luca (Sanofi Ventures)
Viome Life Sciences
Series CAug 2023$10M
$10M
Fertifa
Seed Jun 2023$650K
$7.7M
Co-investors: Malin Posern (Index Ventures), Deepali Nangia (Atomico), Jonathan Lenson (LocalGlobe), Eileen Burbidge (Passion Capital), Adam Knight (Emerge VC), Manuel Antunes (Triple Point Investment Management), Itxaso del Palacio (Notion Capital), Jeremy Yap (Xtripe Angels), Mike Hudack, Tom Blomfield
Alto Neuroscience
Series BJan 2023$7M
$130M
Co-investors: Stephen Hays (What If Ventures), Christian Angermayer (Presight Capital), Michael Liang (Baird Capital), Tim Kendall
PVmed
Series BDec 2022$70K
$70K
BehaVR
Series BDec 2022$1M
$2M
Co-investors: Kelby Price (Keyhorse Capital), Enke Bashllari (Arkitekt Ventures)
SaVia Health
SeedDec 2022$1M
$10M
Co-investors: Jen Ard (Intel Capital), Eric King (Solventum)
Cardiosense
Series ADec 2022$3M
$18M
Co-investors: Daniel Gottlieb (Broadview Ventures), Jeff Terrell (Arboretum Ventures)
Sign in with Google →
Sign in with Google →